Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2010
06/29/2010US7745569 polypeptide comprising amino acid sequences that interact with amyloid plaques containing amyloid beta (A beta ) peptide, useful as carrier molecules to deliver drugs and diagnostic reagents to amyloid plaques
06/29/2010US7745472 Dimethylsulfamic Acid 2-bromo-4-{[(4-cyano-phenyl)-[1,2,4]triazol-4-ylamino]methyl}phenyl Ester, used as effective sulfatase and/or aromatase inhibitors, and as modulators of cell cycling and modulators of apoptosis; therapy of breast, prostate, ovarian or endometrial cancer
06/29/2010US7745407 modulating hepcidin and disease of iron metabolism such as hemochromatosis and anemia of chronic disease; adminstering soluble mammalian hemojuvelin protein
06/29/2010US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
06/29/2010US7745391 Human thrombospondin polypeptide
06/29/2010US7745389 Factor H gene polymorphisms and haplotypes; complement inhibitors
06/29/2010US7745229 Chemoselective fluorgenic molecular linkers and methods for their preparation and use
06/29/2010US7745225 determining extracellular matrix protein of the dermal tissue, obtaining fibroblasts derived from the dermal tissue, determining potential of fibroblasts to synthesize an extracellular matrix protein, determining the DNA content of the fibroblasts, assessing kinetics of fibroblast outgrowth
06/29/2010US7745213 nucleotide sequences coding potassium chanel protein for use in identifying modulator for prevention and treatment of cardiovascular/myocardial disorders; utilized to diagnose and screen for short QT syndrome, long QT syndrome, Brugada syndrome and progressive conduction disease
06/29/2010US7745212 Melanoma antigens and their use in diagnostic and therapeutic methods
06/29/2010US7745205 Container for carrying out and monitoring biological processes
06/29/2010US7745203 Biochip comprising immobilized nucleic acid for use in identifying single nucleotide polymorphism; characterization of allelic mutation in preferential gene sequences
06/29/2010US7745200 selecting a formaldehyde resistant cell; therefore useful as a selectable marker in methylotrophic yeasts; genetic engineering
06/29/2010US7745193 recombinant nucleotide sequence which codes upon expression for at least a part of a bifunctional hybrid active-site serine beta -lactamase protein
06/29/2010US7745190 Endoribonuclease
06/29/2010US7745188 Heat resistant and error-prone polymerase for use as mutational tool in genetic analysis
06/29/2010US7745184 Using transgenic escherichia expressing galactose-proton symporter and reduced glycerolaldehyde 3-phosphate dehydrogenase as bioreactor for 1,3-propanediol production
06/29/2010US7745180 removing erythrocytes and blood components other than leukocytes from the whole blood by filtration, then lysing leukocytes of the whole blood, and quantifying the specific mRNA in the lysate; leukocyte filters attached to oligo(dT)-immobilized multi-well plates; use in diagnosis, blood bank screening
06/29/2010US7745178 Complexity management of genomic DNA
06/29/2010US7745173 Histone deacetylase and methods of use thereof
06/29/2010US7745169 Bioreactor which utilizes spectral emittance as tool in measuring and classifying bacterial growth
06/29/2010US7745168 Detection in samples; staining with Ponceau S and treating with the cationic carbocyanine dye 1-Ethyl-2-[3-(1-ethylnaphtho[1,2-d]thiazolin-2-ylidene)-2-methylpropenyl]naphtho[1,2-d]thiazolium bromide to form light stable complex detectable by light microscopes
06/29/2010US7745167 for the in situ measurement of biological materials to allow for measuring high optical density (OD) levels and/or biomass concentration
06/29/2010US7745166 Human lysosomal protein and methods of its use
06/29/2010US7745165 Calibration of colorectal cancer; gene expression profile; administering to human an antibody which binds to protein markers
06/29/2010US7745164 Methods of modulating apoptosis using inhibitors of brain-localized protein kinases homologous to homeodomain-interacting protein kinases
06/29/2010US7745163 contacting sample with a reagent comprising a thiol-containing compound, a halo-acetyl-CoA or a halo-acetyl-pantetheine, and an acetyltransferase under conditions suitable for acetyltransferase enzyme activity then identifying a substrate that has formed a base-stable covalent bond to the reagent
06/29/2010US7745160 Method of amplifying ATP and use thereof
06/29/2010US7745157 Enhancing an immune response to an antigen in a mammal by administering lymphocyte conditioned median based on a mixture of cytokines and chemokines obtained from peripheral blood mononuclear cells stimulated with antiCD3/CD28-coated beads; used with traditional vaccines or cancer immunotherapy
06/29/2010US7745156 Methods for diagnosis and treatment of epithelial-derived cancers
06/29/2010US7745154 Preventives/remedies for myeloma tumor and method of diagnosing the same
06/29/2010US7745152 Method for determining genotoxicity
06/29/2010US7745142 Molecular modification assays
06/29/2010US7745138 Methods for determining drug responsiveness
06/29/2010US7745137 analyzing two polymorphisms in stromelysin 1 gene and plasminogen activator inhibitor-1 gene in a nucleic acid sample; high accuracy and predictability
06/29/2010US7745136 detecting activity of a ribosome inactivating protein; cleaving said product with an endonuclease; product is hybridized to a template and cleaved by an apurinic/apyrimidinic endonuclease such that releasing the blocked 3' end only in a sample that contains RIP activity
06/29/2010US7745135 Method for detecting reaction product of nucleic acid synthesis
06/29/2010US7745134 Using single-stranded RNA sequences as evaluative tools in prognosing therapeutic efficacy of antitumor treatments
06/29/2010US7745133 Using polymorphisms in nijimegen breakage syndrome-1 genes (NBS-1) as diagnostic and prognostic tool in predicting cell proliferative disorders such as prostate and/or breast cancer
06/29/2010US7745132 Prognostic indicators of canine lymphoid neoplasia using tumor-derived plasma DNA
06/29/2010US7745131 High throughput genome specific molecular markers for erucic acid content genes in Brassica napus
06/29/2010US7745130 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
06/29/2010US7745129 using labeled molecule probes comprising a probe element for binding to a target molecule, attached to a label-assembly; spatially separating these structures and extending the label assemblies such that the information encoded structures can be individually resolved, substantially simultaneously
06/29/2010US7745128 identification of cancer risk factors and methods for early diagnosis and therapy for cancers; detecting mutated Ras in a test sample cells expressing a mutant Ras having a substitution of a glycine, a lysine, or a glutamine for the glutamate at position 76 with respect to the wild-type Ras
06/29/2010US7745127 obtaining a sample from the subject's frontal cortex, analyzing the level of expression of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene, wherein reduced levels of expression of UCH-L1 gene compared to controls is diagnostic of DLB; Alzheimer's Disease and Parkinson's disease
06/29/2010US7745126 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions.
06/29/2010US7745125 2′-terminator related pyrophosphorolysis activated polymerization
06/29/2010US7745124 Performing a hybridization reaction in the reaction temperature region of a reaction solution using oligonucleotides
06/29/2010US7745123 non-destructive and dynamic means for determining the cell cycle position of living cells; methods for measuring the effect of a test agent on the cell cycle position
06/29/2010US7745122 Analyzing messenger RNA and micro RNA in the same reaction mixture
06/29/2010US7745121 Polymorphism in the macrophage migration inhibitory factor (MIF) gene as marker for prostate cancer
06/29/2010US7745120 Cell culture and method for screening for a compound useful in the treatment or prevention of hepatic cirrhosis
06/29/2010US7745119 detecting the presence or amount of a target polynucleotide; detecting the presence of a disease state; detecting infection of a host by a pathogen, genetic variation, genetically modified organism, strain of an organism
06/29/2010US7745118 identifying genetic mutations in a test genome of an organism relative to a reference genome of the an organism; resequencing DNA using microarrays to rapidly map and identify SNPs, deletions and amplification events present in the genome of an organism; high-throughput mutation mapping
06/29/2010US7745117 Designing target specific sequences for use as tool in genetic analysis and gene therapy; gene expression inhibition; RNA interference
06/29/2010US7745116 Polymerase-nucleic acid complex comprising anchor which irreversibly associates target nucleotide with multimeric complex for use as tool in enhancing polymerase processivity in DNA sequencing
06/29/2010US7745115 monitoring for the presence of potentially harmful agents released as an act of terrorism, or by accident; treating the sample to reduce the concentration of bacteria that are bioencapsulated by Tetrahymena pyriformis relative to the bioencapsulation of Bacillus anthracis,
06/29/2010US7745114 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
06/29/2010US7745113 in vitro methods of expansion and propagation of undifferentiated progenitor cells containing Islet1, a marker unique to proliferating cardiac stem cells; done without differentiation to provide cardiac repair or improve cardiac function
06/29/2010US7745112 predicting a response of a human subject to a nicotine replacement treatment designed to assist smoking cessation; screening a smokers DNA for the presence and genotype of dopamine beta -hydroxylase 1368 alleles and dopamine D2 receptor Taq I RFLP alleles; nicotine replacement treatment
06/29/2010US7745111 Molecular markers of plant embryogenesis
06/29/2010US7745110 Adipogenic adenoviruses as a biomarker for disease
06/29/2010US7745109 Regulation of cell growth by MUC1
06/29/2010US7745108 Method for identifying terpene synthase
06/29/2010US7745107 Method for assaying flowing media for microbial toxins
06/29/2010US7745066 mixing polyvinyl alcohol, and cellular membrane-free proteorhodopsin in an aqueous solution, solidifying; used as optical data storage material or a fraud-proof carrier; produces a photocyle when exposed to light of excitation wavelength; security ink; easy to produce the protein, expressed in E. coli
06/29/2010US7744907 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
06/29/2010US7744901 A reassortant influenza virus comprises 6 internal genome segments from A/Ann Arbor/6/60 and one genome segment comprising a nucleic acid encoding a hemagglutinin polypeptide comprising the amino acid sequence of SEQ ID NO: 11; live, split or killed vaccine; immunostimulants
06/29/2010US7744896 therapeutic vaccine anti-HIV, anti-AIDS and against tumors and syndromes associated with HIV infection
06/29/2010US7744888 Controlling immunology response; autoimmune disease, antiallergens
06/29/2010US7744887 Human scFvs which interact with a conformational epitope along the pre-hairpin, N-helix coiled coil structure within the heptad repeat 1 (HR1) region of gp41 of HIV; reducing viral load levels within an infected individual
06/29/2010US7744886 Methods for interfering with rank signaling
06/29/2010US7744878 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/29/2010US7744873 Extracting DNA from a blood or buccal cell sample, PCR, resolution, and identification of differences in sequences between the extracted DNA and PCR primers; drug screening
06/29/2010US7744816 For medical diagnostics, forensics, toxicology, pathology, biological warfare, public health
06/29/2010CA2575640C Method of measuring the number of bacteria, device of measuring the number of bacteria and cell used in the device
06/29/2010CA2512279C Method for preparing lactate biosensing strip
06/29/2010CA2447871C Biosensor membranes composed of polymers containing heterocyclic nitrogens
06/29/2010CA2410460C Probes for imaging protein phosphorylation and dephosphorylation and method for detecting and determining protein phosphorylation and dephosphorylation using the same
06/29/2010CA2358439C Metastasis models using green fluorescent protein (gfp) as a marker
06/29/2010CA2319665C Processes for isolating, amplifying and characterizing dna
06/29/2010CA2286795C Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
06/29/2010CA2252372C Pathogenic escherichia coli associated protein
06/29/2010CA2251560C Pesticidal toxins
06/29/2010CA2218364C Screening assay for the identification of inhibitors of macrophage migration inhibitory factor
06/29/2010CA2187740C Dna encoding bradykinin b1 receptor
06/29/2010CA2134030C Soluble interferon .alpha.-receptor, its preparation and use
06/24/2010WO2010071881A1 Method for confirming a diagnosis of rolandic epilepsy
06/24/2010WO2010071833A1 Proteinase k inhibitors, methods and compositions therefor
06/24/2010WO2010071821A1 Diagnostic test for mutations in codons 12-13 of human k-ras
06/24/2010WO2010071694A1 Method for determining sensitivity or resistance to compounds that activate the brain serotonin system
06/24/2010WO2010071602A1 Pcr-based method of synthesizing a nucleic acid molecule
06/24/2010WO2010071462A1 Peptides mimicking urease, methods of manufacturing, application in diagnostic tests and the way of performance the test
06/24/2010WO2010071431A1 Method of breeding cysdv-resistant cucumber plants
06/24/2010WO2010071405A1 Markers for detecting predisposition for risk, incidence and progression of osteoarthritis
06/24/2010WO2010071249A2 The diagnosing method of cancer using dosage sensitive gene group and methylation degree of methyl transition zone thereof
06/24/2010WO2010071206A1 DNA CONSTRUCT FOR TRANSCRIPTION/EXPRESSION OF siRNA, AND USE THEREOF
06/24/2010WO2010071147A1 Method for detecting controls for nucleic acid amplification, and use thereof
06/24/2010WO2010071114A1 Method for detecting cancer cells in blood sample
06/24/2010WO2010070637A2 Method for distinguishing between adrenal tumors